Related Experiment Video
Updated: Jan 25, 2026

Assessing Respiratory Immune Responses to Haemophilus Influenzae
Published on: June 29, 2021
Abstract:
In two clinical trials, the CD122-preferential IL2 pathway agonist bempegaldesleukin increased proliferation and activation of tumor-infiltrating lymphocytes in patients with solid tumors. Despite the lack of response to the agent as a monotherapy in the first-in-human trial, patients with metastatic urothelial carcinoma in the subsequent PIVOT-02 trial did respond when the drug was combined with the PD-1 inhibitor nivolumab.
Insights
Bempegaldesleukin, an IL-2 pathway agonist, boosts anti-tumor immune cells. Combining it with nivolumab showed promise in urothelial carcinoma patients, unlike monotherapy.
Area of Science:
- Immunology
- Oncology
- Pharmacology
Background:
- Bempegaldesleukin selectively targets the CD122 receptor, activating the IL-2 pathway.
- Clinical trials investigated bempegaldesleukin's effect on tumor-infiltrating lymphocytes (TILs) in solid tumors.
Discussion:
- Monotherapy with bempegaldesleukin showed limited efficacy in initial trials.
- Combination therapy of bempegaldesleukin with nivolumab (a PD-1 inhibitor) demonstrated a response in metastatic urothelial carcinoma.
Key Insights:
- Bempegaldesleukin enhances the proliferation and activation of TILs.
- The synergistic effect of bempegaldesleukin and nivolumab is crucial for treating specific cancers.
- Tumor-infiltrating lymphocyte activation is a key mechanism.
Outlook:
- Further research into combination immunotherapies is warranted.
- Exploring bempegaldesleukin in other solid tumor indications could be beneficial.
- Optimizing treatment strategies for urothelial carcinoma may involve novel drug combinations.
Related Concept Videos
Humoral Immune Responses
Cell-mediated Immune Responses
Cells of the Adaptive Immune Response
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Cells of the Innate Immune Response
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...

